Meningococcal carriage among Georgia and Maryland high school students

Journal of Infectious Diseases

Volumn 211, Issue 11, 2015, Pages 1761-1768

  Harrison, Lee H ^a,c   Shutt, Kathleen A ^c   Arnold, Kathryn E ^d,e   Stern, Eric J ^f,g   Pondo, Tracy ^f   Kiehlbauch, Julia A ^b   Myers, Robert A ^b   Hollick, Rosemary A ^a   Schmink, Susanna ^f   Vello, Marianne ^d,e   Stephens, David S ^d,h,i   Messonnier, Nancy E ^f   Mayer, Leonard W ^f   Clark, Thomas A ^f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Georgia Emerging Infections Program   (United States)

^e Public Health Division   (United States)

^f NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

high school students; meningococcal; meningococcal conjugate vaccine; meningococcus; Neisseria meningitidis; oropharyngeal carriage

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL CAPSULE; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM ISOLATE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIGH SCHOOL STUDENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; OROPHARYNX; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SINGLE DRUG DOSE; THROAT CULTURE; UNITED STATES; CLASSIFICATION; GEORGIA; HETEROZYGOTE; IMMUNOLOGY; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; NEISSERIA MENINGITIDIS; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; STUDENT; YOUNG ADULT;

ADOLESCENT; ADULT; CARRIER STATE; FEMALE; GEORGIA; HUMANS; MALE; MARYLAND; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; PROSPECTIVE STUDIES; RISK FACTORS; STUDENTS; YOUNG ADULT;

EID: 84930427267     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu679     Document Type: Article

References (33)

1. Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010; 50:184-91.
2. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54:1-21.
3. Prevention and control of meningococcal disease. MMWR Recomm Rep 2013; 62:1-22.
4. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969; 129:1327-48.
5. Maiden MC, Stuart JM. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 2002; 359:1829-31.
6. MacLennan J, Kafatos G, Neal K, et al. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 2006; 12:950-7.
7. Imrey PB, Jackson LA, Ludwinski PH, et al. Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak. J Clin Microbiol 1995; 33:3133-7.
8. Stuart JM, Cartwright KA, Robinson PM, Noah ND. Effect of smoking on meningococcal carriage. Lancet 1989; 2:723-5.
9. Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987; 99:591-601.
10. Riordan T, Cartwright K, Andrews N, et al. Acquisition and carriage of meningococci in marine commando recruits. Epidemiol Infect 1998; 121:495-505.
11. Bruce MG, Rosenstein NE, Capparella JM, Shutt KA, Perkins BA, Collins M. Risk factors for meningococcal disease in college students. JAMA 2001; 286:688-93.
12. Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive meningococcal disease in adolescents and young adults. JAMA 2001; 286:694-9.
13. Harrison LH, Dwyer DM, Maples CT, Billmann L. Risk of meningococcal infection in college students. JAMA 1999; 281:1906-10.
14. Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10:853-61.
15. Greenfield S, Sheehe PR, Feldman HA. Meningococcal carriage in a population of "normal" families. J Infect Dis 1971; 123:67-73.
16. O'Brien KL, Millar EV, Zell ER, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007; 196:1211-20.
17. Barbour ML, Mayon-White RT, Coles C, Crook DW, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995; 171:93-8.
18. Maiden MC, Ibarz-Pavon AB, Urwin R, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 2008; 197:737-43.
19. Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 2001; 357:195-6.
20. Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 2003; 326:365-6.
21. Kristiansen PA, Diomande F, Ba AK, et al. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis 2013; 56:354-63.
22. Kellerman SE, McCombs K, Ray M, et al. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. J Infect Dis 2002; 186:40-8.
23. Centers for Disease Control and Prevention. National vaccination coverage among adolescents aged 13-17 years - United States, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:885-8.
24. Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:1100-3.
25. Mothershed EA, Sacchi CT, Whitney AM, et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol 2004; 42:320-8.
26. Harrison LH, Shutt KA, Schmink SE, et al. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era - United States, 2000-2005. J Infect Dis 2010; 201:1208-24.
27. Neal KR, Nguyen-Van-Tam JS, Jeffrey N, et al. Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ 2000; 320:846-9.
28. Ala'aldeen DA, Oldfield NJ, Bidmos FA, et al. Carriage of meningococci by university students, United Kingdom. Emerg Infect Dis 2011; 17: 1762-3.
29. Oppermann H, Thriene B, Irmscher HM, et al. Meningococcal carriers in high school students and possible risk factors [in German]. Gesundheitswesen 2006; 68:633-7.
30. Harrison OB, Claus H, Jiang Y, et al. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis 2013; 19: 566-73.
31. Read RC, Baxter D, Chadwick DR, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet 2014; 384:2123-31.
32. Jackson LA, Baxter R, Reisinger K, et al. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents. Clin Infect Dis 2009; 49:e1-10.
33. Bidmos FA, Neal KR, Oldfield NJ, Turner DP, Ala'Aldeen DA, Bayliss CD. Persistence, replacement, and rapid clonal expansion of meningococcal carriage isolates in a 2008 university student cohort. J Clin Microbiol 2011; 49:506-12.